Anthropic has acquired Mithril Medicine, a drug discovery startup run by a single person, as part of its push into the life sciences, Endpoints News reported on October 27. The startup was backed by Atlas Venture, and its founder operated the Professor Oak account on X under a pseudonym.
No price or terms were disclosed in the reporting available for this edition, and the item is carried at grade C for that reason. What is established is the structure: an artificial intelligence company acquiring, rather than licensing or partnering with, a drug discovery effort small enough to be one person. Anthropic has been building a life sciences business alongside its models, and a one person acquisition is an acqui hire of a method, not of a pipeline.
The read for the sector is about where AI drug discovery value sits. If a major AI laboratory will buy a solo founder’s stealth company, the scarce asset is a working discovery workflow and the person who built it, not headcount or wet laboratory scale.